“…[36,[49][50][51] The recent development of biomolecular sensors and designer cells processing and transmitting physiological information to electronic devices as well as electronic devices programming cellular release of biopharmaceuticals in response to light, [17] or direct electrical fields, [7,21,52] has led to the establishment of electro-genetic interfaces that enable reversible communication between biology and electronics, [36,53] sparking visions of novel treatments based on bioelectronic implants. [54,55] No matter whether such bioelectronic devices and implants use light as the middle-man for electro-genetic control, [7,17,18] or direct electro-genetic interfaces based on electrical fields, [21] they all require substantial electrical energy to support monitoring, processing, and communication. [32] Therefore, currently available bioelectronic implants cannot be operated on battery power, but require wired, [18] or wireless power, [6,7] for continuous operation, which limits selfsufficiency, reliability, and patient convenience.…”